Lobbying Information
Subject Matters
- Budget
- Environment
- Government Procurement
- Health
- Industry
- Intellectual Property
- International Relations
- International Trade
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Federal Budget & Budget measures act with respect to health care funding and focus on science & technology strategy
Policies or Program
- Federal Chemicals Management Plan - with repsect to specific batch chemical reviews that may include a chemical used in our manufacturing operations in Canada
- Patented Medicines Prices Review Board (PMPRB) policies and guidelines - with respect to the implementation of the revised excessive price guidelines
- Science & Technology strategy with respect to the impact on commcercialization of medical technology in Canada
- Subsequent Entry Biologics (SEB's) policy guidelines - with repsect to exemptions for blood/plasma-derived products, recombinant technology and/or cell-gene-based technologies
Regulation
- Regulations to Amend the Food and Drugs Act - with respect to provisions that would impact approvals and product life-cycle management for medical devices and biopharmacetucials, subsequent entry biologics regulations, orphan/rare disease direction and the disclosure of confidential business information
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Canada Border Services Agency (CBSA)
-
Environment Canada
-
Federal Economic Development Agency for Southern Ontario (FedDev)
-
Finance Canada (FIN)
-
Foreign Affairs and International Trade Canada (DFAITC)
-
Health Canada (HC)
-
House of Commons
-
Industry Canada
-
National Defence (DND)
-
Office of the Procurement Ombudsman (OPO)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Public Safety Canada (PS)
-
Public Works and Government Services Canada
-
Senate of Canada
In-house Corporation Details
Description of activities
Baxter Corporation (Canada) is the Canadian subsidiary of Baxter International, a global health care company. Baxter's BioScience, Medication Delivery and Renal products and services are used to treat Canadians with such medical conditions as cancer, hemophilia, immune deficiencies, infectious diseases, kidney disease and trauma.
Responsible officer name and position during the period of this registration
Barbara Leavitt,
General Manager
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
7125 Mississauga Rd.
Mississauga, ON L5N 0C2
Canada
Telephone number:
905-369-6453
Parent Company Information
- Baxter International
-
One Baxter Parkway
Deerfield, IL 60015-4625
United States of America
Subsidiary Beneficiary Information
Baxter Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Lisa Armour,
Director, Regulatory Affairs |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Saurabh Popat,
Director Government Affairs & Public Policy |
No public offices held
